CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays

Molecular and Cellular Proteomics

Volumn 11, Issue 6, 2012, Pages

  He, Jintang ^a   Liu, Yashu ^a   Zhu, Thant ^a   Zhu, Jianhui ^a   DiMeco, Francesco ^c,d   Vescovi, Angelo L ^e   Heth, Jason A ^a   Muraszko, Karin M ^a   Fan, Xing ^a,b,c   Lubman, David M ^a,d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; THY 1 ANTIGEN; TUMOR MARKER; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER STEM CELL; CELL DIFFERENTIATION; CELL POPULATION; CELL RENEWAL; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROSPHERE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; STEM CELL NICHE; TISSUE MICROARRAY; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; BRAIN TUMOR; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; MULTICELLULAR SPHEROID; PATHOLOGY; VASCULARIZATION;

ADULT; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, THY-1; ASTROCYTOMA; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; SPHEROIDS, CELLULAR; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84862317152     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.010744     Document Type: Article

References (37)

1. Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P. L., Burkhard, C., Schüler, D., Probst-Hensch, N. M., Maiorka, P. C., Baeza, N., Pisani, P., Yonekawa, Y., Yasargil, M. G., Lütolf, U. M., and Kleihues, P. (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res. 64, 6892-6899 (Pubitemid 39330996)
2. Reardon, D. A., Rich, J. N., Friedman, H. S., and Bigner, D. D. (2006) Recent advances in the treatment of malignant astrocytoma. J. Clin. Oncol. 24, 1253-1265 (Pubitemid 46622028)
3. Reya, T., Morrison, S. J., Clarke, M. F., and Weissman, I. L. (2001) Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (Pubitemid 33041634)
4. Visvader, J. E., and Lindeman, G. J. (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768
5. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983-3988 (Pubitemid 36418143)
6. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., and Dirks, P. B. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (Pubitemid 37187480)
7. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., and Dirks, P. B. (2004) Identification of human brain tumour initiating cells. Nature 432, 396-401 (Pubitemid 39551674)
8. Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., and Vescovi, A. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021 (Pubitemid 39331011)
9. Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., and Rich, J. N. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760 (Pubitemid 44949604)
10. Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., and Yu, J. S. (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5, 67
11. Piccirillo, S. G., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., and Vescovi, A. L. (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444, 761-765 (Pubitemid 44949605)
12. Fan, X., Khaki, L., Zhu, T. S., Soules, M. E., Talsma, C. E., Gul, N., Koh, C., Zhang, J., Li, Y. M., Maciaczyk, J., Nikkhah, G., Dimeco, F., Piccirillo, S., Vescovi, A. L., and Eberhart, C. G. (2010) NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28, 5-16
13. Fan, X., Matsui, W., Khaki, L., Stearns, D., Chun, J., Li, Y. M., and Eberhart, C. G. (2006) Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66, 7445-7452 (Pubitemid 44289197)
14. Fan, X., and Eberhart, C. G. (2008) Medulloblastoma stem cells. J. Clin. Oncol. 26, 2821-2827
15. Zhu, T. S., Costello, M. A., Talsma, C. E., Flack, C. G., Crowley, J. G., Hamm, L. L., He, X., Hervey-Jumper, S. L., Heth, J. A., Muraszko, K. M., DiMeco, F., Vescovi, A. L., and Fan, X. (2011) Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res. 71, 6061-6072
16. Bao, S., Wu, Q., Li, Z., Sathornsumetee, S., Wang, H., McLendon, R. E., Hjelmeland, A. B., and Rich, J. N. (2008) Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 68, 6043-6048
17. Eyler, C. E., Foo, W. C., LaFiura, K. M., McLendon, R. E., Hjelmeland, A. B., and Rich, J. N. (2008) Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 26, 3027-3036
18. Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., Hjelmeland, A. B., and Rich, J. N. (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15, 501-513
19. Wang, H., Lathia, J. D., Wu, Q., Wang, J., Li, Z., Heddleston, J. M., Eyler, C. E., Elderbroom, J., Gallagher, J., Schuschu, J., MacSwords, J., Cao, Y., McLendon, R. E., Wang, X. F., Hjelmeland, A. B., and Rich, J. N. (2009) Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 27, 2393-2404
20. Guryanova, O. A., Wu, Q., Cheng, L., Lathia, J. D., Huang, Z., Yang, J., MacSwords, J., Eyler, C. E., McLendon, R. E., Heddleston, J. M., Shou, W., Hambardzumyan, D., Lee, J., Hjelmeland, A. B., Sloan, A. E., Bredel, M., Stark, G. R., Rich, J. N., and Bao, S. (2011) Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 19, 498-511
21. Eyler, C. E., Wu, Q., Yan, K., MacSwords, J. M., Chandler-Militello, D., Misuraca, K. L., Lathia, J. D., Forrester, M. T., Lee, J., Stamler, J. S., Goldman, S. A., Bredel, M., McLendon, R. E., Sloan, A. E., Hjelmeland, A. B., and Rich, J. N. (2011) Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 146, 53-66
22. Giltnane, J. M., and Rimm, D. L. (2004) Technology insight: Identification of biomarkers with tissue microarray technology. Nat. Clin. Pract. Oncol. 1, 104-111 (Pubitemid 40823750)
23. Leth-Larsen, R., Lund, R. R., and Ditzel, H. J. (2010) Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol. Cell. Proteomics 9, 1369-1382
24. Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., and Beier, C. P. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67, 4010-4015 (Pubitemid 46815044)
25. Wang, J., Sakariassen, P. Ø., Tsinkalovsky, O., Immervoll, H., Boe, S. O., Svendsen, A., Prestegarden, L., Rosland, G., Thorsen, F., Stuhr, L., Molven, A., Bjerkvig, R., and Enger, P. O. (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122, 761-768
26. Pfenninger, C. V., Roschupkina, T., Hertwig, F., Kottwitz, D., Englund, E., Bengzon, J., Jacobsen, S. E., and Nuber, U. A. (2007) CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res. 67, 5727-5736 (Pubitemid 46985005)
27. Joo, K. M., Kim, S. Y., Jin, X., Song, S. Y., Kong, D. S., Lee, J. I., Jeon, J. W., Kim, M. H., Kang, B. G., Jung, Y., Jin, J., Hong, S. C., Park, W. Y., Lee, D. S., Kim, H., and Nam, D. H. (2008) Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab. Invest. 88, 808-815
28. He, J., Liu, Y., Xie, X., Zhu, T., Soules, M., DiMeco, F., Vescovi, A. L., Fan, X., and Lubman, D. M. (2010) Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach. J. Proteome Res. 9, 2565-2572
29. Baum, C. M., Weissman, I. L., Tsukamoto, A. S., Buckle, A. M., and Peault, B. (1992) Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. U.S.A. 89, 2804-2808
30. Dennis, J. E., Esterly, K., Awadallah, A., Parrish, C. R., Poynter, G. M., and Goltry, K. L. (2007) Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. Stem Cells 25, 2575-2582 (Pubitemid 47582750)
31. Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W., Lam, C. T., Poon, R. T., and Fan, S. T. (2008) Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13, 153-166 (Pubitemid 351163165)
32. He, J., Liu, Y., He, S., Wang, Q., Pu, H., and Ji, J. (2007) Proteomic analysis of a membrane skeleton fraction from human liver. J. Proteome Res. 6, 3509-3518 (Pubitemid 47522742)
33. Bar, E. E., Chaudhry, A., Lin, A., Fan, X., Schreck, K., Matsui, W., Piccirillo, S., Vescovi, A. L., DiMeco, F., Olivi, A., and Eberhart, C. G. (2007) Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25, 2524-2533 (Pubitemid 47582744)
34. He, J., Liu, Y., Zhu, T. S., Xie, X., Costello, M. A., Talsma, C. E., Flack, C. G., Crowley, J. G., Dimeco, F., Vescovi, A. L., Fan, X., and Lubman, D. M. (2011) Glycoproteomic analysis of glioblastoma stem cell differentiation. J. Proteome Res. 10, 330-338
35. Masson, N. M., Currie, I. S., Terrace, J. D., Garden, O. J., Parks, R. W., and Ross, J. A. (2006) Hepatic progenitor cells in human fetal liver express the oval cell marker Thy-1. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G45-54 (Pubitemid 44026382)
36. Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K. E., Geber, A., Fligelman, B., Leversha, M., Brennan, C., and Tabar, V. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468, 829-833
37. Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., and De Maria, R. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468, 824-828